Literature DB >> 988516

Autoradiographic studies of cultures of cerebrospinal fluid lymphocytes in nonsuppurative meningitis.

Y A Malashkhia, M G Geladze.   

Abstract

Morphologic and autoradiographic studies of cerebrospinal fluid lymphocytes in nonsuppurative meningitis showed that, in addition to blast cells synthesizing DNA in response to mitogens, blast cells not incorporating thymidine were present. The autoradiographic studies also showed small lymphocytes of the usual sizes incorporating 3H thymidine, indicating that they were in the growth phase of the cell cycle. The magnitude of the response of CSF lymphocytes from patients with tuberculous meningitis to purified protein derivative appeared specific. A response of this degree may be of value in the early diagnosis of tuberculous meningitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 988516     DOI: 10.1212/wnl.26.11.1081

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Anti-purified protein derivative cell-enzyme-linked immunosorbent assay, a sensitive method for early diagnosis of tuberculous meningitis.

Authors:  S M Baig
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

2.  Intrathecal synthesis of immunoglobulin G and Mycobacterium tuberculosis-specific humoral immune response in tuberculous meningitis.

Authors:  T Y Cho; S C Park; S N Cho; H R Lee; S K Kim; S K Kim; B I Lee
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

3.  [Autoradiographic findings in cerebrospinal fluid cells (author's transl)].

Authors:  H W Kölmel
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-08-22

4.  Differential diagnosis of tuberculous meningitis from partially-treated pyogenic meningitis by cell ELISA.

Authors:  Rajpal S Kashyap; Rani P Kainthla; Ravindra M Satpute; Neha P Agarwal; Nitin H Chandak; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  BMC Neurol       Date:  2004-10-22       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.